Ganesh Venkataraman Kaundinya

2011

In 2011, Ganesh Venkataraman Kaundinya earned a total compensation of $1.5M as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 58% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$138,592
Option Awards$221,786
Salary$359,980
Stock Awards$789,975
Other$12,018
Total$1,522,351

Kaundinya received $790K in stock awards, accounting for 52% of the total pay in 2011.

Kaundinya also received $138.6K in non-equity incentive plan, $221.8K in option awards, $360K in salary and $12K in other compensation.

Rankings

In 2011, Ganesh Venkataraman Kaundinya's compensation ranked 4,155th out of 10,747 executives tracked by ExecPay. In other words, Kaundinya earned more than 61.3% of executives.

ClassificationRankingPercentile
All
4,155
out of 10,747
61st
Division
Manufacturing
1,472
out of 3,960
63rd
Major group
Chemicals And Allied Products
300
out of 1,033
71st
Industry group
Drugs
174
out of 781
78th
Industry
Biological Products, Except Diagnostic Substances
23
out of 157
85th
Source: SEC filing on April 23, 2012.

Kaundinya's colleagues

We found five more compensation records of executives who worked with Ganesh Venkataraman Kaundinya at Momenta Pharmaceuticals in 2011.

2011

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2011

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Scientific Officer

2011

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2011

James Roach

Momenta Pharmaceuticals

Chief Medical Officer

2011

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like